Wird geladen...

Real‐World Assessment of Clinical Outcomes Among First‐Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group

BACKGROUND: International Metastatic Renal Cell Carcinoma (mRCC) Database Consortium (IMDC) risk groups are important when considering therapeutic options for first‐line treatment. MATERIALS AND METHODS: Adult patients with clear cell mRCC initiating first‐line sunitinib between 2010 and 2018 were i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncologist
Hauptverfasser: Savard, Marie‐France, Wells, J. Connor, Graham, Jeffrey, Dudani, Shaan, Steinharter, John A., McGregor, Bradley A., Donskov, Frede, Bjarnason, Georg A., Vaishampayan, Ulka N., Hansen, Aaron R., Iafolla, Marco A.J., Zanotti, Giovanni, Huynh, Lynn, Chang, Rose, Duh, Mei S., Heng, Daniel Y.C.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons, Inc. 2020
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7216460/
https://ncbi.nlm.nih.gov/pubmed/31971318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0605
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!